|
| Variables | All patients | Uncomplicated procedures | Major complications | Minor complications | Periprocedural death | 30-day mortality |
| all procedures |
|
| Number of patients (number, %) | 1915 (100%) | 1790 (93.5%) | 34 (1.8%) | 91 (4.8%) | 7 (0.4%) | 28 (1.5%) |
|
| Patient-dependent risk factors |
|
| Patient’s age at TLE (mean, SD median, IQR) | 64.83 | 64.99 | | | | |
| ±15.95 | ±15.73 | ±17.20 | ±18.91 | ±11.06 | ±10.20 |
| 68.00 | 68.00 | 67.00 | 69.00 | 72.00 | 72,00 |
| [58.00-76.00] | [58.00-76.00] | 3-7 | [56.00-76.00] | [65.00-80.00] | [65.00-80.00] |
|
| Female gender (n, %) | 822 (42.90) | 749 (41.20) | (70.60) | (53.80) | (71.4) | (57.1) |
|
| BMI (kg/m2) (mean, SD median, IQR) | 27.48 | 27.29 | | | | |
| ±6.82 | ±4.12 | ±3.59 | ±3.96 | ±1.86 | ±4.68 |
| 27.14 | 27.28 | 26.70 | 25.83 | 26.37 | 25.76 |
| [24.03-30.44) | [24.03-30.47] | [24.86-30.19] | [22.49-29.75] | [25.48-27.24] | [21.23-27.76] |
|
| NYHA functional class (mean, SD median, IQR) | 1.64 | 1.64 | | | | |
| ±0.72 | ±0.72 | ±0.71 | ±0.71 | ±0.79 | ±0.89 |
| 2 - | 2 - | 1 - | 1- | 1- | 2- |
|
| NYHA classes I and II (n, %) | 1675 (87.50) | 1566 (87.50) | (88.20) | (86.80) | (85.7) | (60.7) |
|
| NYHA classes III and IV (n, %) | 240 (12.50) | 224 (12.50) | (11.80) | (13.20) | (14.3) | (39.3) |
|
| Left ventricular ejection fraction LVEF (mean, SD median, IQR) | 38.91 | 38.74 | | | | |
| ±13.40 | ±13.40 | ±13.26 | ±13.48 | ±14.64 | ±14.03 |
| 41.88 | 41.88 | 45.54 | 44.53 | 42.00 | 34.95 |
| [30.24-46.53] | [29.47-46.53] | [34.01-48.59] | [37.37-47.71] | [29.50-50.00] | [21.28-37.99] |
|
| Diabetes types I and II (n, %) | 357 (18.6) | 335 (18.7) | (11.8) | (19.8) | (14.3) | (35.7) |
|
| Chronic renal failure (CRF) creatinine level (mean, SD median, IQR) | 1.17 | 1.16 | | | | |
| ±0.73 | ±0.69 | ±0.67 | ±1.30 | ±0.62 | ±1.61 |
| 1.00 | 1.00 | 1.00 | 1.10 | 1.10 | 1.50 |
| [0.84-1.28] | [0.88-1.25] | [0.80-1.25] | [0.80-1.30] | [1.00-1.30] | [1.20-2.10] |
|
| CRF creatinine level>2 mg/dl (n, %) | 107 (5,59) | 93 (5.20) | (11.8) | (11.0) | (14.3) | (35.7) |
|
| Malignancy (n, %) | 116 (6.06) | 109 (6.09) | (5.88) | (5.49) | (14.3) | (7.14) |
|
| Hemoglobin concentration (mean, SD median, IQR) | 13.17 | 13.2 | | | | |
| ±2.79 | ±1.83 | ±2.23 | ±2.29 | ±2.00 | ±2.59 |
| 13.30 | 13.40 | 12.15 | 11.80 | 13.00 | 12.20 |
| [12.00-14.40] | [12.10-14.40] | [10.40-14.00] | [10.70-13.70] | [11.50-14.20] | [8.80-13.60] |
|
| Hemoglobin concentration<12 g/dl (n,%) | 463 (24.18) | 396 (22.12) | (44.12) | (47.25) | (28.57) | (50) |
|
| Valvular cardiac implant (n, %) | 113 (5.90) | 100 (5.59) | (2.94) | (13.3) | (0.00) | (10.7) |
|
| Prior sternotomy (n, %) | 291 (15.2) | 256 (14.90) | (5.88) | (25.3) | (0.00) | (28.6) |
|
| Permanent AF (n, %) | 429 (22.4) | 406 (22.7) | (14.7) | 18 (19.8) | 2 (28.6) | 10 (35.7) |
|
| Chronic anticoagulation (n, %) | 653 (34.1) | 617 (34.5) | 8 (23.5) | 28 (30.8) | 2 (28.6) | 11 (39.3) |
|
| Chronic antiplatelet therapy (n, %) | 798 (41.7) | 764 (42.7) | 10 (29.4) | (26.4) | 1 (14.3) | 10 (35.7) |
|
| Cardiac device infections (n, %) | 773 (41.3) | 716 (40.0) | 12 (35.3) | 45 (49.5) | 5 (71.4) | (78.6) |
|
| Lead-related infective endocarditis (LRIE) ( n%) | 527 (27.5) | 480 (26.8) | 11 (32.4) | (39.6) | 4 (57.1) | (67.9) |
|
| Isolated LRIE (n, %) | 217 (11.3) | 191 (10.7) | 7 (20.6) | (20.9) | 3 (42.9) | (39.3) |
|
| Pocket infection (PI) (n, %) | 556 (29.0) | 525 (29.3) | 5 (14.7) | 26 (28.6) | 2 (28.6) | 11 (39.3) |
|
| Vegetations (n, %) | 383 (20.0) | 347 (19.4) | 7 (20.6) | 29 (31.9) | 2 (28.6) | (50.0) |
|
Large vegetations
(2-4 vs. 0-1 cm) (n, %) | 209 (10.9) | 182 (10.2) | 6 (17.6) | 21 (23.1) | (28.6) | (32.1) |
|
| Vegetations connected with heart wall (n, %) | 37 (1.93) | 34 (1.90) | 0 (0.00) | 4 (4.40) | 0 (0.00) | 2 (7.14) |
|
| Multiple vegetations (n, %) | 191 (9.97) | 173 (9.66) | 3 (8.82) | 15 (16.5) | 1 (14.3) | (25.0) |
|
